In spinal MNs, glycine receptor (Glra2) is lowly expressed compared to CN3/4 MNs but increases in ALS, possibly as a delayed compensatory mechanism to restore inhibition. The gene discussed is GLRA2; the disease is amyotrophic lateral sclerosis.